Important note: Information in this article was accurate in 2006. The state of the art may have changed since the publication date.
|
|
BBC News (12.28.06) - Thursday, December 28, 2006
An oral sample is sent from home off to a laboratory, which looks for HIV antibodies in the saliva. If the results are negative, results are sent out via e-mail. If the $49 US (25 pounds) test detects signs of an immune response to HIV in the saliva, the service offers a phone call from a health professional. Patients are also advised to seek a formal diagnosis from a genito-urinary clinic.
Home test kits have been previously banned due to a lack of on-hand counseling.
The Dr. Thom test is unlikely to detect recent HIV infection since only people who have been infected for approximately 14 weeks will test positive. Also, the test is not as accurate as the standard blood test offered in clinics, and this will still be required in order to confirm infection. "The test can tell if a person shows no signs of HIV, but is unable to make a firm diagnosis," said a Dr. Thom spokesperson.
Annabel Kanabus, director of the AIDS charity Avert, said the target audience for the test is the "worried well." "I would still recommend that if people are genuinely worried they may have HIV, they should go to a local [National Health Service] genito-urinary clinic to be tested," she said. "The blood test is more reliable than a saliva test, and it is free of charge. In addition, counseling is available on the spot, unlike this service."
061228
AD062512
Copyright © 2006 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.
Always watch for outdated information. This article first appeared in 2006. This material is designed to support, not replace, the relationship that exists between you and your doctor.AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2006. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.
.